WuXi Biologics secures FTSE4Good inclusion for sixth straight year

The Hong Kong-listed CRDMO said it ranked in the top 4% of the global health care sector on ESG performance this year, reinforcing its Green CRDMO sustainability strategy.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.